Login

CEO Spotlight: MeridianLink CEO Nicolaas Vlok shares what excites him most about joining the #NYSECommunity now that his company is public. 00:10:00

Share On Facebook Share On Twitter

Nicolaas Vlok | CEO - MeridianLink, Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
CEO's Reflection on Sustainable Growth and Integration in Real Estate Development |Panote Sirivadhanabhakdi, Group CEO , Frasers Property.
00:10:00
Group 6 Metals Aims for First Tungsten Concentrate Production Early Next Year | Keith McKnight, CEO , Group 6 Metals Ltd.
00:10:00
IronRidge Resources: African Gold and Lithium Assets
00:10:00
Operating as a bridge between Silicon Valley, the corporate brand world, and the entertainment industry|Rachel Springate,Founding Partner,Muse Capital
00:10:00
Advancing the Broken Hill Cobalt Project: Insights from Cobalt Blue CEO at the One-to-One Mining Conference in Hong Kong
00:10:00
Desert Lion Energy: Fast-Tracking Lithium Production in Namibia
00:10:00
PetVivo's Innovative OsteoCushion Targets Root Cause of Osteoarthritis in Pets, Promises Major Market Potential|John Lai,CEO,PetVivo Holdings Inc
00:10:00
Exploring High-Grade Gold Deposits in Victoria, Australia
00:10:00
Understanding the Key Differences Between Medicare and Medicaid for Elder Law
00:10:00
Wealth Minerals' Strategic Overview: Lithium Market Trends and Cusco Project Update.
00:10:00
Market Risks Intensify Amid Ukraine Crisis | Sébastien Page, CIO , T. Rowe Price.

© 2017 - Neuhu+